OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are used in PCOS both for cycle regulation and to reduce the biologically active androgen fraction. We examined COCP use and risk of dysglycemia (prediabetes and type 2 diabetes) in women with PCOS. RESEARCH DESIGN AND METHODS: Using a large U.K. primary care database (The Health Improvement Network [THIN]; 3.7 million patients from 787 practices), we carried out a retrospective population-based cohort study to determine dysglycemia risk (64,051 ...
Background: PCOS is a complex endocrine disorder characterized by menstrual dysfunction, anovulation...
Objective: Many complex diseases exhibit co-morbidities often requiring management by more than one ...
Abstract Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8–13%. Given the prevalen...
OBJECTIVE Irregular menstrual cycles are associated with increased cardiovascular mortality. Poly...
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dysli...
Objective: Many complex diseases exhibit co-morbidities often requiring management by more than one ...
[[abstract]]BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproducti...
Introduction This population-based follow-up study investigated the comorbidities, medication use, a...
Objective: To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS...
Combined oral contraceptives (COC) are the most often used treatment modality for polycystic ovary s...
�� 2019 The Author(s). Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopath...
Background: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary sy...
First published: 20 March 2023Objective: As part of the update of the International Evidence‐Based G...
STUDY QUESTION What are the respective roles of polycystic ovary syndrome (PCOS), long-term weight g...
Introduction: Combined oral contraceptives (COCs) are a commonly used contraceptive method. They are...
Background: PCOS is a complex endocrine disorder characterized by menstrual dysfunction, anovulation...
Objective: Many complex diseases exhibit co-morbidities often requiring management by more than one ...
Abstract Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8–13%. Given the prevalen...
OBJECTIVE Irregular menstrual cycles are associated with increased cardiovascular mortality. Poly...
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dysli...
Objective: Many complex diseases exhibit co-morbidities often requiring management by more than one ...
[[abstract]]BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproducti...
Introduction This population-based follow-up study investigated the comorbidities, medication use, a...
Objective: To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS...
Combined oral contraceptives (COC) are the most often used treatment modality for polycystic ovary s...
�� 2019 The Author(s). Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopath...
Background: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary sy...
First published: 20 March 2023Objective: As part of the update of the International Evidence‐Based G...
STUDY QUESTION What are the respective roles of polycystic ovary syndrome (PCOS), long-term weight g...
Introduction: Combined oral contraceptives (COCs) are a commonly used contraceptive method. They are...
Background: PCOS is a complex endocrine disorder characterized by menstrual dysfunction, anovulation...
Objective: Many complex diseases exhibit co-morbidities often requiring management by more than one ...
Abstract Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8–13%. Given the prevalen...